Related Experiment Video
Updated: Aug 31, 2025

08:58
Optogenetic Manipulation of Neural Circuits During Monitoring Sleep/wakefulness States in Mice
Published on: June 19, 2019
9.9K
Melatonin Decreases Acute Inflammatory Response to Neural Probe Insertion.
Daniela D Krahe1, Kevin M Woeppel1,2, Qianru Yang1,2,3
1Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15260, USA.
Antioxidants (Basel, Switzerland)
|August 26, 2022
Summary
Melatonin administration reduces acute inflammation and oxidative stress around neural implants. This antioxidant treatment preserves neuron density and improves neural interface stability.
Area of Science:
- Neuroscience
- Biomaterials Science
- Pharmacology
Background:
- Neural electrode implantation causes trauma, leading to inflammation and oxidative stress.
- This neuroinflammation impairs neural tissue health and the long-term function of neural implants.
- The acute effects of melatonin on neuroinflammation post-implantation are not well understood.
Purpose of the Study:
- To investigate the acute effects of melatonin on neuroinflammation and oxidative stress following neural electrode implantation.
- To evaluate melatonin's impact on glial cell activation and neuronal survival in the early post-implantation period.
Main Methods:
- Histological analysis and quantitative PCR (q-PCR) were used to assess inflammation and oxidative stress markers.
- Two-photon microscopy tracked microglial responses in real-time in transgenic mice.
- Mice (C57BL/6) received neural implants with or without melatonin treatment.
Main Results:
- Melatonin treatment maintained neuron density and reduced glial cell activation (microglia and astrocytes).
- Significant reduction in pro-inflammatory cytokines (TNF-α, IL-6) and oxidative damage was observed.
- Melatonin inhibited microglial encapsulation of the implant surface.
Conclusions:
- Melatonin effectively mitigates acute neuroinflammation and oxidative stress around neural implants.
- Melatonin promotes more stable and reliable neural interfaces by reducing detrimental tissue responses.
- These findings support melatonin's potential for both acute and chronic modulation of implant-associated inflammation.

